Aviva’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-31,069
| Closed | -$5.74M | – | 856 |
|
|
2024
Q4 | $5.74M | Buy |
31,069
+29,137
| +1,508% | +$5.38M | 0.01% | 519 |
|
|
2024
Q3 | $381K | Sell |
1,932
-8,241
| -81% | -$1.62M | ﹤0.01% | 844 |
|
|
2024
Q2 | $2.1M | Buy |
10,173
+8,233
| +424% | +$1.7M | 0.01% | 575 |
|
|
2024
Q1 | $526K | Buy |
1,940
+29
| +2% | +$7.86K | ﹤0.01% | 861 |
|
|
2023
Q4 | $452K | Hold |
1,911
| – | – | ﹤0.01% | 881 |
|
|
2023
Q3 | $375K | Sell |
1,911
-34
| -2% | -$6.66K | ﹤0.01% | 915 |
|
|
2023
Q2 | $409K | Sell |
1,945
-59,026
| -97% | -$12.4M | ﹤0.01% | 900 |
|
|
2023
Q1 | $12.3M | Buy |
60,971
+50,900
| +505% | +$10.3M | 0.06% | 432 |
|
|
2022
Q4 | $2.19M | Sell |
10,071
-20,994
| -68% | -$4.57M | 0.01% | 696 |
|
|
2022
Q3 | $6.11M | Sell |
31,065
-9,497
| -23% | -$1.87M | 0.04% | 537 |
|
|
2022
Q2 | $8.68M | Buy |
40,562
+7,940
| +24% | +$1.7M | 0.05% | 478 |
|
|
2022
Q1 | $9.26M | Buy |
32,622
+16,270
| +99% | +$4.62M | 0.05% | 449 |
|
|
2021
Q4 | $6.16M | Sell |
16,352
-7,435
| -31% | -$2.8M | 0.03% | 533 |
|
|
2021
Q3 | $9.82M | Buy |
23,787
+14,577
| +158% | +$6.02M | 0.04% | 401 |
|
|
2021
Q2 | $3.41M | Buy |
+9,210
| New | +$3.41M | 0.01% | 681 |
|